| Dr Harold Sanchez, MD | |
|
100 Grand St, New Britain, CT 06052-2016 | |
| (860) 224-5584 | |
| (860) 224-5946 |
| Full Name | Dr Harold Sanchez |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 100 Grand St, New Britain, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891743894 | NPI | - | NPPES |
| 004199057P1 | Other | CT | BLUE CARE NBG GRP# |
| 0007217043 | Other | CT | AETNA USHC |
| 9471244001 | Other | CT | CIGNA |
| 615577 | Other | CT | CONNECTICARE GRP# |
| 004199057P2 | Other | CT | BLUE CARE BMH GRP# |
| 0V6399 | Other | CT | HEALTHNET GROUP# |
| 1104295 | Other | CT | UNITED HEALTHCARE GRP# |
| 500HBL433CT01 | Other | CT | BC/BS NBG GRP# |
| 500HBL433CT02 | Other | CT | BC/BS BMH GRP# |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 33314 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, with 5,000 to 6,000 new cases per year in the United States.
This is with great pride that Green Cross Biotherapeutics Inc. kicked off construction today on its biopharmaceutical facility that will be located on the Montreal Technoparc's Saint-Laurent Campus. The CA$315 million project represents one of the largest green field investment projects in Canada in the biopharmaceutical industry, giving place to the construction of the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Canada.
There has been a lot of debate regarding the effectiveness of breast cancer screening in the UK. It is being reviewed yet again. The NHS says screening saves lives, but other researchers have argued that it may cause more harm than good.
CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .
› Verified 3 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, with 5,000 to 6,000 new cases per year in the United States.
This is with great pride that Green Cross Biotherapeutics Inc. kicked off construction today on its biopharmaceutical facility that will be located on the Montreal Technoparc's Saint-Laurent Campus. The CA$315 million project represents one of the largest green field investment projects in Canada in the biopharmaceutical industry, giving place to the construction of the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Canada.
There has been a lot of debate regarding the effectiveness of breast cancer screening in the UK. It is being reviewed yet again. The NHS says screening saves lives, but other researchers have argued that it may cause more harm than good.
CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .
› Verified 3 days ago
| Entity Name | Hartford Pathology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063464477 PECOS PAC ID: 8729989561 Enrollment ID: O20040115000745 |
News Archive
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, with 5,000 to 6,000 new cases per year in the United States.
This is with great pride that Green Cross Biotherapeutics Inc. kicked off construction today on its biopharmaceutical facility that will be located on the Montreal Technoparc's Saint-Laurent Campus. The CA$315 million project represents one of the largest green field investment projects in Canada in the biopharmaceutical industry, giving place to the construction of the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Canada.
There has been a lot of debate regarding the effectiveness of breast cancer screening in the UK. It is being reviewed yet again. The NHS says screening saves lives, but other researchers have argued that it may cause more harm than good.
CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harold Sanchez, MD Po Box 1730, New Haven, CT 06507-1730 Ph: (203) 397-8000 | Dr Harold Sanchez, MD 100 Grand St, New Britain, CT 06052-2016 Ph: (860) 224-5584 |
News Archive
In recent years, researchers have identified specific gene mutations linked to gastrointestinal stromal tumors (GIST), which primarily occur in the stomach or small intestine, with 5,000 to 6,000 new cases per year in the United States.
This is with great pride that Green Cross Biotherapeutics Inc. kicked off construction today on its biopharmaceutical facility that will be located on the Montreal Technoparc's Saint-Laurent Campus. The CA$315 million project represents one of the largest green field investment projects in Canada in the biopharmaceutical industry, giving place to the construction of the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Canada.
There has been a lot of debate regarding the effectiveness of breast cancer screening in the UK. It is being reviewed yet again. The NHS says screening saves lives, but other researchers have argued that it may cause more harm than good.
CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .
› Verified 3 days ago
Dr. Alexander Vdovenko, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5584 Fax: 860-224-5946 | |
Dr. Lakshmi Sarma, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5584 Fax: 860-224-5946 | |
Dr. David Krugman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5584 Fax: 860-224-5946 | |
Dr. Barry Jacobs, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5584 Fax: 860-224-5946 | |
Dr. Lisa Laird, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5584 Fax: 860-224-5946 |